Juliana Segabinazzi Saldanha

Juliana Segabinazzi Saldanha

Auto-generated profile, based on publicly available information

Juliana Segabinazzi Saldanha

Clinical Nutrition Department, Nutrition Faculty, Federal University Fluminense (UFF), Niterói, Brazil

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Journal of Renal Nutrition
Verified
Journal Article
Closed access
JSJuliana F. Saldanha
Juliana F. Saldanha
VLViviane O. Leal
Viviane O. Leal
FRFelipe Rizzetto
Felipe Rizzetto
GGGustavo H. Grimmer
Gustavo H. Grimmer
MRMarcelo Ribeiro-Alves
Marcelo Ribeiro-Alves
Denise MafraDenise Mafra
Denise Mafra

29 December 2013 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
JSJuliana F. Saldanha
Juliana F. Saldanha
VLViviane de O. Leal
Viviane de O. Leal
PSPeter Stenvinkel
Peter Stenvinkel
JCJosé Carlos Carraro-Eduardo
José Carlos Carraro-Eduardo
Denise MafraDenise Mafra
Denise Mafra
Resveratrol, a phenolic compound found in various plants, including grapes, berries, and peanuts, shows promise for the treatment of cancer, aging, type 2 diabetes, and cardiovascular diseases. Resveratrol can promotetranscription factor nuclear factor-erythroid 2-related factor 2(Nrf2) activation, increase the expression level of SIRT-1, which is a sirtuin family protein, and reduce mTOR pathway signaling. This compound has anti-inflammatory properties in that it inhibits or antagonizes the nuclear factor-κB (NF-κB) activity, which is a redox-sensitive transcription factor that coordinates the inflammatory response. Inflammation and oxidative stress, which are common features in patients with chronic kidney disease (CKD), are interrelated and associated with cardiovascular disease and the progression of CKD itself. Because of the modulation of the mechanisms involved in the inflammatory-oxidative stress cycle, resveratrol could play an important role in controlling CKD-related metabolic derangements. Although resveratrol supplementation in theory is a promising therapy in this patient group, there are no studies evaluating its effects. Thus, the present review aims to describe the role of resveratrol in inflammation and oxidative stress modulation and its possible benefits to patients with CKD.

26 October 2011 in Regulatory Peptides
Verified
Journal Article
Closed access
JSJ.F. Saldanha
J.F. Saldanha
JCJ.J. Carrero
J.J. Carrero
JLJ.C. Lobo
J.C. Lobo
MSMilena Barcza Stockler-Pinto
Milena Barcza Stockler-Pinto
VLV.O. Leal
V.O. Leal
Denise MafraDenise Mafra
Denise Mafra

3 February 2022 in Journal of Renal Nutrition
Verified
Journal Article
Closed access
PDF file
Livia AlvarengaLivia Alvarenga
Livia Alvarenga
LCLudmila Cardozo
Ludmila Cardozo
VLViviane de O. Leal
Viviane de O. Leal
Julie Ann KempJulie Ann Kemp
Julie Ann Kemp
JSJuliana F. Saldanha
Juliana F. Saldanha
Denise MafraDenise Mafra
Denise Mafra

1 June 2016 in Biochimie
Verified
Journal Article
Closed access
JSJuliana F. Saldanha
Juliana F. Saldanha
DYDan Yi
Dan Yi
MSMilena Barcza Stockler-Pinto
Milena Barcza Stockler-Pinto
HSHédi A. Soula
Hédi A. Soula
SCStéphane Chambert
Stéphane Chambert
CSChristophe O. Soulage
Christophe O. Soulage

31 October 2011 in Medical Hypotheses
Verified
Journal Article
Closed access
JSJ.F. Saldanha
J.F. Saldanha
JCJ.J. Carrero
J.J. Carrero
Denise MafraDenise Mafra
Denise Mafra